Chugai Pharmaceutical Co., Ltd. (CHGCF)
USD 43.95
(44.76%)
USD 43.95
(44.76%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 273.48 Billion JPY | -6.41% |
| 2022 | 292.2 Billion JPY | 39.92% |
| 2021 | 208.83 Billion JPY | 13.56% |
| 2020 | 183.89 Billion JPY | 9.38% |
| 2019 | 168.12 Billion JPY | 5.5% |
| 2018 | 159.36 Billion JPY | -5.74% |
| 2017 | 169.05 Billion JPY | -8.84% |
| 2016 | 185.44 Billion JPY | 15.08% |
| 2015 | 161.13 Billion JPY | 15.45% |
| 2014 | 139.57 Billion JPY | 8.59% |
| 2013 | 128.53 Billion JPY | 18.04% |
| 2012 | 108.89 Billion JPY | 3.72% |
| 2011 | 104.98 Billion JPY | 0.09% |
| 2010 | 104.88 Billion JPY | 13.22% |
| 2009 | 92.64 Billion JPY | 17.66% |
| 2008 | 78.73 Billion JPY | 42.67% |
| 2007 | 55.18 Billion JPY | -10.31% |
| 2006 | 61.53 Billion JPY | 29.7% |
| 2005 | 47.44 Billion JPY | -18.09% |
| 2004 | 57.91 Billion JPY | 8.95% |
| 2003 | 53.15 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 265.7 Billion JPY | -3.97% |
| 2024 Q1 | 276.68 Billion JPY | 1.17% |
| 2023 Q1 | 278.85 Billion JPY | -4.57% |
| 2023 Q3 | 277.46 Billion JPY | 4.15% |
| 2023 Q2 | 266.4 Billion JPY | -4.47% |
| 2023 FY | 273.48 Billion JPY | -6.41% |
| 2023 Q4 | 273.48 Billion JPY | -1.44% |
| 2022 Q3 | 313.01 Billion JPY | 43.28% |
| 2022 Q4 | 292.2 Billion JPY | -6.65% |
| 2022 Q2 | 218.46 Billion JPY | -3.11% |
| 2022 Q1 | 225.48 Billion JPY | 7.97% |
| 2022 FY | 292.2 Billion JPY | 39.92% |
| 2021 FY | 208.83 Billion JPY | 13.56% |
| 2021 Q1 | 184.65 Billion JPY | 0.42% |
| 2021 Q2 | 199.16 Billion JPY | 7.85% |
| 2021 Q3 | 201.42 Billion JPY | 1.13% |
| 2021 Q4 | 208.83 Billion JPY | 3.68% |
| 2020 Q2 | 172.05 Billion JPY | -1.32% |
| 2020 Q1 | 174.35 Billion JPY | 3.71% |
| 2020 Q3 | 179.57 Billion JPY | 4.37% |
| 2020 FY | 183.89 Billion JPY | 9.38% |
| 2020 Q4 | 183.89 Billion JPY | 2.4% |
| 2019 Q1 | 168.72 Billion JPY | 5.88% |
| 2019 FY | 168.12 Billion JPY | 5.5% |
| 2019 Q2 | 167.69 Billion JPY | -0.61% |
| 2019 Q4 | 168.12 Billion JPY | -0.49% |
| 2019 Q3 | 168.95 Billion JPY | 0.75% |
| 2018 Q3 | 163.84 Billion JPY | -3.62% |
| 2018 Q4 | 159.36 Billion JPY | -2.73% |
| 2018 Q1 | 168.09 Billion JPY | -0.57% |
| 2018 FY | 159.36 Billion JPY | -5.74% |
| 2018 Q2 | 169.99 Billion JPY | 1.13% |
| 2017 Q4 | 169.05 Billion JPY | -4.89% |
| 2017 Q2 | 188.25 Billion JPY | -0.64% |
| 2017 Q1 | 189.46 Billion JPY | 2.17% |
| 2017 FY | 169.05 Billion JPY | -8.84% |
| 2017 Q3 | 177.74 Billion JPY | -5.58% |
| 2016 Q4 | 185.44 Billion JPY | -0.9% |
| 2016 FY | 185.44 Billion JPY | 15.08% |
| 2016 Q1 | 167.3 Billion JPY | 3.83% |
| 2016 Q3 | 187.11 Billion JPY | 7.83% |
| 2016 Q2 | 173.53 Billion JPY | 3.72% |
| 2015 Q4 | 161.13 Billion JPY | 4.43% |
| 2015 Q3 | 154.3 Billion JPY | 5.75% |
| 2015 Q2 | 145.91 Billion JPY | -1.25% |
| 2015 FY | 161.13 Billion JPY | 15.45% |
| 2015 Q1 | 147.75 Billion JPY | 5.86% |
| 2014 FY | 139.57 Billion JPY | 8.59% |
| 2014 Q1 | 129.47 Billion JPY | 0.73% |
| 2014 Q4 | 139.57 Billion JPY | -7.55% |
| 2014 Q3 | 150.97 Billion JPY | 6.49% |
| 2014 Q2 | 141.77 Billion JPY | 9.5% |
| 2013 Q3 | 128.57 Billion JPY | 12.69% |
| 2013 Q4 | 128.53 Billion JPY | -0.03% |
| 2013 Q2 | 114.09 Billion JPY | -1.78% |
| 2013 FY | 128.53 Billion JPY | 18.04% |
| 2013 Q1 | 116.15 Billion JPY | 6.67% |
| 2012 FY | 108.89 Billion JPY | 3.72% |
| 2012 Q1 | 101.24 Billion JPY | -3.56% |
| 2012 Q2 | 99.41 Billion JPY | -1.8% |
| 2012 Q3 | 101.27 Billion JPY | 1.86% |
| 2012 Q4 | 108.89 Billion JPY | 7.52% |
| 2011 FY | 104.98 Billion JPY | 0.09% |
| 2011 Q4 | 104.98 Billion JPY | -9.29% |
| 2011 Q2 | 110.44 Billion JPY | 1.78% |
| 2011 Q1 | 108.51 Billion JPY | 3.46% |
| 2011 Q3 | 115.73 Billion JPY | 4.79% |
| 2010 Q3 | 115.9 Billion JPY | 3.76% |
| 2010 Q4 | 104.88 Billion JPY | -9.51% |
| 2010 FY | 104.88 Billion JPY | 13.22% |
| 2010 Q2 | 111.7 Billion JPY | 11.75% |
| 2010 Q1 | 99.96 Billion JPY | 7.9% |
| 2009 Q4 | 92.64 Billion JPY | 2.48% |
| 2009 Q3 | 90.4 Billion JPY | -3.82% |
| 2009 Q2 | 93.99 Billion JPY | 19.48% |
| 2009 Q1 | 78.66 Billion JPY | 0.0% |
| 2009 FY | 92.64 Billion JPY | 17.66% |
| 2008 FY | 78.73 Billion JPY | 42.67% |
| 2007 FY | 55.18 Billion JPY | -10.31% |
| 2006 FY | 61.53 Billion JPY | 29.7% |
| 2005 FY | 47.44 Billion JPY | -18.09% |
| 2004 FY | 57.91 Billion JPY | 8.95% |
| 2003 FY | 53.15 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | -4949.165% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | -10173.479% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | -61712.965% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -1923918.573% |
| Novartis AG | 5.91 Billion USD | -4525.063% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | -60500.973% |